Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1985 | 1 |
2018 | 3 |
2023 | 1 |
2024 | 2 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma.
N Engl J Med. 2023 May 11;388(19):1767-1778. doi: 10.1056/NEJMoa2212851.
N Engl J Med. 2023.
PMID: 37163623
Free PMC article.
Clinical Trial.
Multidisciplinary treatment strategies in high-risk resectable melanoma: Role of adjuvant and neoadjuvant therapy.
McKean MA, Amaria RN.
McKean MA, et al.
Cancer Treat Rev. 2018 Nov;70:144-153. doi: 10.1016/j.ctrv.2018.08.011. Epub 2018 Aug 29.
Cancer Treat Rev. 2018.
PMID: 30195813
Free article.
Review.
Item in Clipboard
Challenges and Opportunities of Neoadjuvant Treatment in Locally Advanced Melanoma.
McKean MA, Amaria RN.
McKean MA, et al.
Am J Clin Dermatol. 2018 Oct;19(5):639-646. doi: 10.1007/s40257-018-0371-8.
Am J Clin Dermatol. 2018.
PMID: 30039289
Item in Clipboard
A next-generation BRAF inhibitor overcomes resistance to BRAF inhibition in patients with BRAF-mutant cancers using pharmacokinetics-informed dose escalation.
Yaeger R, McKean MA, Haq R, Beck JT, Taylor MH, Cohen JE, Bowles DW, Gadgeel SM, Mihalcioiu C, Papadopoulos KP, Diamond EL, Sturtz KB, Feng G, Drescher SK, Reddy MB, Sengupta B, Maity AK, Brown SA, Singh A, Brown EN, Baer BR, Wong J, Mou TC, Wu WI, Kahn DR, Gadal S, Rosen N, Gaudino JJ, Lee PA, Hartley DP, Rothenberg SM.
Yaeger R, et al. Among authors: mckean ma.
Cancer Discov. 2024 Apr 30. doi: 10.1158/2159-8290.CD-24-0024. Online ahead of print.
Cancer Discov. 2024.
PMID: 38691346
Item in Clipboard
Targeting the HGF/MET Axis Counters Primary Resistance to KIT Inhibition in KIT-Mutant Melanoma.
Oba J, Kim SH, Wang WL, Macedo MP, Carapeto F, McKean MA, Van Arnam J, Eterovic AK, Sen S, Kale CR, Yu X, Haymaker CL, Routbort M, Haydu LE, Bernatchez C, Lazar AJ, Grimm EA, Hong DS, Woodman SE.
Oba J, et al. Among authors: mckean ma.
JCO Precis Oncol. 2018;2018:PO.18.00055. doi: 10.1200/PO.18.00055. Epub 2018 Jun 5.
JCO Precis Oncol. 2018.
PMID: 30094412
Free PMC article.
No abstract available.
Item in Clipboard
First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors.
Yarchoan M, Powderly JD, Bastos BR, Karasic TB, Crysler OV, Munster PN, McKean MA, Emens LA, Saenger YM, Ged Y, Stagg R, Smith S, Whiting CC, Moon A, Prasit P, Jenkins Y, Standifer N, Dubensky TW, Whiting SH, Ulahannan SV.
Yarchoan M, et al. Among authors: mckean ma.
Cancer Res Commun. 2024 Apr 18;4(4):1100-1110. doi: 10.1158/2767-9764.CRC-24-0082.
Cancer Res Commun. 2024.
PMID: 38551394
Free PMC article.
Clinical Trial.
Item in Clipboard
The evolution of Japanese images of the environment.
McKean MA.
McKean MA.
Int Asianforum. 1985;16(1-2):25-48.
Int Asianforum. 1985.
PMID: 11617198
No abstract available.
Item in Clipboard
Cite
Cite